Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients

• Sponsor: Washington University School of Medicine (Other)
• Overall Status: Completed
• CT.gov ID: NCT01113099
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI) (NIH)
• Enrollment: 247
• Location: 1
• Arms: 2
• Duration (Months): 12
• Patients Per Site Per Month: 20.6

Study Details

Study Description

Brief Summary

We hypothesize that when compared to usual care a greater proportion of hospitalized diabetic patients who are candidates for cholesterol lowering will be discharged with a prescription for a statin if their physicians are contacted by a pharmacist to discuss treatment guidelines.

Condition or Disease	Intervention/Treatment	Phase
Diabetes; Dyslipidemia	Other: Academic detailing	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 247 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Health Services Research
• Official Title: Assisted Detailing to Improve Guideline Adherence
• Study Start Date: Jun 1, 2006
• Actual Primary Completion Date: Jun 1, 2007
• Actual Study Completion Date: Jun 1, 2007

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Academic detailing of physicians	Other: Academic detailing; Education of physicians by pharmacists regarding indications for statins in diabetic patients
No Intervention: Usual care

Outcome Measures

Primary Outcome Measures

1. Statin prescription at hospital discharge [Hospital discharge (avg = 3 days)]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Hospitalized patients with diabetes

• LDL >= 100

Exclusion Criteria:

• Terminal illness

• Pregnancy

• Intolerance or contraindication to statin

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Barnes Jewish Hospital	St. Louis	Missouri	United States	63110

Sponsors and Collaborators

• Washington University School of Medicine
• National Heart, Lung, and Blood Institute (NHLBI)

Investigators

• Principal Investigator: Thomas C Bailey, MD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT01113099
• Other Study ID Numbers: 02-1072; R01HL070790
• First Posted: Apr 29, 2010
• Last Update Posted: Apr 29, 2010
• Last Verified: Apr 1, 2010

• Additional relevant MeSH terms: Dyslipidemias

Study Results

No Results Posted as of Apr 29, 2010